Skip to main content
. Author manuscript; available in PMC: 2019 Jul 5.
Published in final edited form as: Arch Toxicol. 2017 Sep 26;91(12):3811–3821. doi: 10.1007/s00204-017-2076-9

Fig. 1.

Fig. 1

Exposures to iAs and MAs3+ decreased glycogen content and increased free glucose concentration in primary murine hepatocytes. Hepatocytes were exposed to iAs3+ (a, c) or MAs3+ (b, d) for 4 h with or without insulin treatment (100 nM) for the last 2 h of the exposure. Glycogen (a, b) and free glucose (c, d) were measured in cell lysates. MTT assay was used to assess cell viability in hepatocytes exposed to iAs3+ (e) or MAs3+ (f) for 4 h with insulin treatment (100 nM) for the last 2 h of the exposure. Values are expressed as mean and SD for three independent experiments. *Statistically significant differences (p < 0.05) between control hepatocytes and control hepatocytes treated with insulin, and #between insulin-treated control hepatocytes and insulin-treated hepatocytes exposed to arsenicals; p values for marginally significant differences are also shown